The first single-dose COVID-19 vaccine could receive emergency approval in just two weeks, Dr. Anthony Fauci said late Friday.
“I would be surprised if in two weeks from now the data will be analyzed and decisions made” about the vaccine developed by Johnson & Johnson in New Jersey, Fauci said during an appearance on “The Rachel Maddow Show. ”
“We will analyze the data and determine if it is ready to be given to the public,” Fauci said, “so they can go to the FDA to ask if they can get an emergency use authorization.”
Fauci said the US government is working with several companies on six vaccine candidates, two of whom have already obtained approval for emergency use, one from Pfizer PFE.
and the other from Moderna MRNA,
Both require cold storage and two doses.
J&J JNJ,
The vaccine does not have the same need to be kept very cold, Fauci said, and requires a single dose. These factors will make a big difference in the ability to convey people’s photos, he said. “It offers a wider range of flexibility,” he said.
Johnson & Johnson said it expects to have 100 million doses available by April.
Any additional vaccine available will be a boost for the city and state, which have no more doses, as New York struggles with vaccination schedules. Mayor Bill de Blasio wrote a letter to President Joe Biden on Friday, calling for more shipments of vaccines.
This article was first published on NYPost.com